Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total revenues	$ 4,839	$ 4,817	$ 9,489	$ 9,524
Gross profit	2,002	1,940	3,904	3,831
Selling, general, and administrative	1,067	1,072	2,105	2,134
Research and development	327	298	651	568
Total operating expenses	1,395	1,370	2,756	2,702
Operating income	608	570	1,148	1,129
Interest and other financial charges – net	131	137	254	273
Non-operating benefit (income) costs	(101)	(123)	(204)	(238)
Other (income) expense – net	(1)	(14)	8	(22)
Income before income taxes	578	570	1,090	1,116
Benefit (provision) for income taxes	(143)	(137)	(267)	(300)
Net income	435	433	823	816
Net (income) loss attributable to noncontrolling interests	(7)	(15)	(21)	(26)
Net income attributable to GE HealthCare	428	418	802	790
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	0	(183)
Net income attributable to GE HealthCare common stockholders	$ 428	$ 418	$ 802	$ 607
Earnings per share attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	$ 0.94	$ 0.92	$ 1.76	$ 1.34
Diluted (in dollars per share)	$ 0.93	$ 0.91	$ 1.75	$ 1.33
Weighted-average number of shares outstanding:
Basic (in shares)	457	455	456	455
Diluted (in shares)	459	458	459	458
Product
Total revenues	$ 3,207	$ 3,213	$ 6,253	$ 6,344
Cost of revenue	2,045	2,084	4,012	4,121
Service
Total revenues	1,632	1,604	3,237	3,180
Cost of revenue	$ 792	$ 793	$ 1,574	$ 1,572